Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis

[1]  R. Gamelli,et al.  Bone Marrow Norepinephrine Mediates Development of Functionally Different Macrophages After Thermal Injury and Sepsis , 2004, Annals of surgery.

[2]  C. Dinarello.  Anti-cytokine therapeutics and infections. , 2003, Vaccine.

[3]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[4]  Y. Suh,et al.  Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein. , 2003, Molecular pharmacology.

[5]  M. Bergmann,et al.  Immunomodulatory effects of vasoactive catecholamines. , 2002, Wiener klinische Wochenschrift.

[6]  G. Bancroft,et al.  Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor‐α and interleukin‐10 , 2001, Immunology.

[7]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[8]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[9]  R. Gamelli,et al.  Norepinephrine Modulates Myelopoiesis After Experimental Thermal Injury With Sepsis , 2001, Annals of surgery.

[10]  R. Gamelli,et al.  Myeloid Commitment Shifts Toward Monocytopoiesis After Thermal Injury and Sepsis , 2001, Annals of surgery.

[11]  Petra Reinke,et al.  Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells , 2000, Molecular and Cellular Biochemistry.

[12]  L. Sigola,et al.  Adrenaline inhibits macrophage nitric oxide production through β1 and β2 adrenergic receptors , 2000, Immunology.

[13]  M. Mittlböck,et al.  Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. , 1999, Shock.

[14]  I. C. Almeida,et al.  Differential inhibitory mechanism of cyclic AMP on TNF‐α and IL‐12 synthesis by macrophages exposed to microbial stimuli , 1999, British journal of pharmacology.

[15]  S. Akira,et al.  Interleukin-10 Receptor Signaling through the JAK-STAT Pathway , 1999, The Journal of Biological Chemistry.

[16]  R. Gamelli,et al.  Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation , 1999, Journal of Neuroimmunology.

[17]  J. Lederer,et al.  The effects of injury on the adaptive immune response. , 1999, Shock.

[18]  D. H. Lee,et al.  Release of tumor necrosis factor-α from coronary smooth muscle : Activation of NF-κB and inhibition by elevated cyclic AMP , 1998 .

[19]  Khusru Asadullah,et al.  Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury , 1998, Nature Medicine.

[20]  E. Vizi,et al.  Isoproterenol regulates tumour necrosis factor, interleukin‐10, interleukin‐6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia , 1997, Immunology.

[21]  O. Lantz,et al.  Regulation of interleukin‐10 production by β‐adrenergic agonists , 1996, European journal of immunology.

[22]  Gregory J. Goodall,et al.  Differential Regulation of the Stability of Cytokine mRNAs in Lipopolysaccharide-activated Blood Monocytes in Response to Interleukin-10* , 1996, The Journal of Biological Chemistry.

[23]  S. Opal,et al.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.

[24]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[25]  J. Keiser,et al.  Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. , 1995, The American journal of physiology.

[26]  T. van der Poll,et al.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood , 1994, Infection and immunity.

[27]  M. Howard,et al.  Biological properties of interleukin 10 , 1992, Journal of Clinical Immunology.

[28]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[29]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[30]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[31]  M. Westfall,et al.  Plasma catecholamines during E. coli bacteremia in conscious rats. , 1988, The American journal of physiology.

[32]  F. Romano,et al.  Cardiac and splenic norepinephrine turnover during septic peritonitis. , 1986, The American journal of physiology.

[33]  I. Chaudry,et al.  Sepsis and septic shock--a review of laboratory models and a proposal. , 1980, The Journal of surgical research.

[34]  R. Bone,et al.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.

[35]  E. Faist.  The mechanisms of host defense dysfunction following shock and trauma. , 1996, Current topics in microbiology and immunology.

[36]  F. Romano,et al.  Plasma catecholamines following cecal ligation and puncture in the rat. , 1987, Circulatory shock.

[37]  C. Benedict,et al.  Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. , 1978, The Quarterly journal of medicine.